About Fabric Genomics
Fabric Genomics focuses on genomic analysis and reporting, using artificial intelligence to provide insights for hospitals and diagnostic labs. Their main product, Fabric Enterprise, analyzes Next-Generation Sequencing (NGS) data to quickly identify genetic variants linked to diseases. The company differentiates itself with its AI algorithm, Fabric GEM, which allows for automated reanalysis of undiagnosed cases over time. The goal is to improve patient outcomes by speeding up the diagnosis of genetic illnesses and reducing healthcare costs.
San Francisco, CaliforniaHeadquarters
2009Year Founded
$29MTotal Funding
SERIES_BCompany Stage
Enterprise Software, AI & Machine Learning, HealthcareIndustries
11-50Employees
Benefits
Competitive compensation
Health benefits and coverage
PTO
Parental leave
Risks
Increasing competition from SOPHiA GENETICS SA and PierianDx Inc. may impact market share.
Reliance on partnerships could pose risks if collaborations do not meet expectations.
Potential regulatory changes in genomic data privacy could increase compliance costs.
Differentiation
Fabric Genomics uses AI to enhance genomic analysis and clinical decision support.
The company offers a SaaS platform for rapid genomic data interpretation.
Fabric GEM algorithm enables automated reanalysis of undiagnosed cases over time.
Upsides
Partnerships with DNAnexus and Oxford Nanopore enhance data analysis speed and scalability.
Collaboration with PlumCare RWE expands reach in newborn genome screening in Greece.
Involvement in Project FIND-OUT supports rapid genetic diagnosis in infants.
Funding
Total raised$28.99 M
Latest valuation$115.00 M
StageSERIES_B
SERIES B
5/31/2016$23
$115.00 MSERIES A
12/31/2013$7
$34.00 M